Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 19 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoFollowing the earlier results, the US Food and Drug Administration (FDA) gave accelerated approval...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 7 days agoThe adjustment comes in the wake of Merck's first-quarter results, which not only featured a robust...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe company’s R&D investment strategy focuses on the area of immuno-oncology and particularly the expansion of its portfolio after the success of its...
3 Investing Pros Lay Out Their Dividend Strategies—and Stock Picks
Barrons.com· 1 day agoIn February, Walmart announced a 9% dividend increase, its largest in more than a decade. Another of...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 1 day agoCancer drugs are highly prized in the industry for their pricing power, favorable reimbursement status...Strong performance of key drugs: Vyndaqel: This...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 21 hours agoLater this month, the Food and Drug Administration will consider approving Moderna's RSV shot...half...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 7 days agoSome of the participants will get a placebo shot though none will know what they are receiving....
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 7 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
